We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and evaluation of clinical research for diverse European populations.
For detailed information about the initiative, please read the following invitation letter from Dr. Axel Glasmacher and Dr. Fergus Sweeney, CDDF Board members and Coordination committee: https://cddf.org/wp-content/uploads/2024/09/CDDF-Diversity-Letter-to-Industry-Association_20240906.pdf
To participate in the CDDF working group, please send an email to info@cddf.org by 30 September 2024.